Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › COHANCE

COHANCE

Cohance Lifesciences Limited
Small-capHealthcare ↗

What the six lenses say about COHANCE — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹449.6
2026-09-08
VWAP · 1Y anchor
₹504
-10.8% from VWAP
P/E · TTM
95.9×
TTM EPS ₹4.7
52-week range
23%
position low→high
RSI(14)
49
momentum

Own sector index

Healthcare ↗
Neutral

1M

-1.1%

3M

+7.1%

1Y

+14.5%

Breadth >EMA21

55%

How COHANCE’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
3.5
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Small-cap cohortDRaw
TechnicalD448›

The actual numbers

Price vs VWAP (1y)-10.8%
EMA trend stackMixed
Price vs 200-EMA-9.6%
Price vs 50-EMA+1.0%
RSI(14)49
RS vs Nifty 500 · 3M+1.5%
RS vs sector · 3M-1.2%
52-week range23%
Volume vs 30d avg1.50×
Volume vs 60d avg1.29×
ATR(14) · volatility18.4
Bollinger width · vol contraction0.075
FundamentalD551›

The actual numbers

Return on equity (ROE)7.0%
Return on capital (ROCE)8.3%
Operating margin10.8%
Net margin6.6%
Revenue growth · YoY+38.7%
EPS growth · YoY-65.5%
Debt / equity0.10×

Full 8-quarter history in the financials table below.

ValuationD519›

The actual numbers

P/E (TTM)95.9×
TTM EPS₹4.7
52-week range23%
CatalystD641›

The actual numbers

Earnings & momentum40
Capital actions16
Governance95

Every filing in the corporate-announcements panel below.

FlowD342›

The actual numbers

Promoter holding57.5%
Delivery · 30d avg45.2%
Up/down-day asymmetry-8.3pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D4 + D3 ) ÷ 2 = 3.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Medium
47
Conviction score 47/100 · avg-decile strength 3.5/10
Conviction score47/100›
TechnicalD4›
FundamentalD5›
ValuationD5›
CatalystD6›
FlowD3›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
-1.0pp
-0.2pp
+5.9pp
+3.1pp
+63.4pp
-51.6pp
Nifty 500
Broad-market baseline
-1.1pp
-0.1pp
+4.8pp
+1.5pp
+57.6pp
-56.8pp
Sector
Own-sector index
—
—
+3.5pp
-1.2pp
+48.9pp
-70.1pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

COHANCE daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
449.55-7.05

Relative strength

RS vs baseline · rebased to 100

COHANCE ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
37.83-0.43

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)231258307840549556545619
↳ change QoQ—+11.7%+19.2%+173.6%-34.6%+1.1%-2.0%+13.7%
EBITDA (₹cr)981181332291121219599
EBITDA margin42.5%45.8%43.4%27.3%20.4%21.8%17.5%15.9%
PAT (₹cr)6182831174666298
↳ change QoQ—+34.9%+1.6%+40.7%-60.4%+43.1%-56.3%-71.4%
Net margin26.3%31.8%27.1%13.9%8.5%11.9%5.3%1.3%
EPS (₹)2.393.233.264.731.281.940.960.51
D/E————————
YoY growth · Mar '26Revenue -26.3% YoYPAT -92.9% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 5 Sep '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 3 Sep '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 3 Sep '26
    LOWgovernance
    Committee Meeting Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 27 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 26 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 26 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 Aug '26
    MEDIUMcapital
    Credit Rating- Others
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 11 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 Aug '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 5 Aug '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 5 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 23 Jul '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 23 Jul '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds COHANCE

Mutual funds holding COHANCE (10)

FundWeightAUM ₹crGrade
SBI Multi Asset Allocation Reg Gr1.10%20,240
DSP Large & Mid Cap Fund Reg Gr0.64%18,231
DSP ELSS Tax Saver Reg Gr0.83%16,738
DSP Flexi Cap Fund Reg Gr0.84%12,422
DSP Agrsv Hybrid Fund Reg Gr1.00%11,909
ICICI Pru Pharma Healthcare Diag Gr3.92%6,803
Aditya BSL Large & Mid Cap Gr0.51%5,827
Invesco India Flexi Cap Reg Gr0.53%5,468
SBI Healthcare Opportunities Reg Gr1.73%5,400
DSP Healthcare Fund Reg Gr3.74%3,639

ETFs holding COHANCE (1)

ETFWeightGrade
Zerodha Nifty Smallcap 100 ETF0.59%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare